Compare Avalanche Treasury Corporation Class A Common Stock (AVAT) vs Davita Inc (DVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Avalanche Treasury Corporation Class A Common Stock vs Davita Inc — how do they compare? Avalanche Treasury Corporation Class A Common Stock trades at $0.34 (market cap $14.82M), while Davita Inc trades at $178.34 (market cap $11.72B). The key difference: Davita Inc is far larger — about 790.8× Avalanche Treasury Corporation Class A Common Stock's market cap, and Davita Inc is trading nearer its 52-week high, Avalanche Treasury Corporation Class A Common Stock nearer its low. Which is the better fit depends on your goals.
| AVAT | DVA | |
|---|---|---|
Market Cap | $14.82M | $11.72B |
Sector | Financials | Health |
52-Week High | $10.75 | $240.96 |
52-Week Low | $0.30 | $103.87 |
Enterprise Value | $14.82M | $24.44B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AVAT trades at $0.33, down 4.35% on the day, with a bearish technical signal from moving averages. The company reported a net income of $8.28 million for 2025, yet shows negative operating cash flow of -$930,710. Recent news highlights its Nasdaq listing, positioning it as an operating company focused on capital allocation within its ecosystem, attracting attention from major financial media.
The outlook is mixed; low P/E of 12 and P/B of 0.4 suggest undervaluation, but negative cash flow and ROA of -7.25% raise sustainability concerns. Risks include execution challenges in capital deployment and market volatility, while institutional interest may grow post-listing, offering potential upside if operational metrics improve.
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Avalanche Treasury Corporation Class A Common Stock
Avalanche Treasury Corp operates as a digital asset treasury company focused on holding and managing digital asset investments. The company was founded on September 22, 2025, and is headquartered in New York, NY.
Read more on AVAT →About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →
